Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT)
Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT)
Recruiting · NCT07286747 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT) | Insulin Resistance, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose intolerance, glucose metabolism disease, hyperglycemia, hyperinsulinism, metabolic disease, prediabetes syndrome | Recruiting | Phase 2 | 2026-09-16 | NCT07286747 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Hospital Schleswig-Holstein | 49 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Charité-Universitätsmedizin Berlin | Berlin | Germany | 1 |
| TUM University Hospital | München | Germany | 1 |
| University Hospital Schleswig-Holstein (UKSH) | Lübeck | Germany | 1 |
| University Hospital Tübingen | Tübingen | Germany | 14 |
| University Medical Center Schleswig-Holstein, Campus Kiel | Kiel | Germany | 2 |
| University of Leipzig Medical Center | Leipzig | Germany | 2 |